Fleury S.A. (BVMF:FLRY3)

Market Cap	9.23B +44.4%
Revenue (ttm)	8.07B +6.9%
Net Income	600.42M -2.1%
EPS	1.10 -4.8%
Shares Out	545.02M
PE Ratio	15.36
Forward PE	14.17
Dividend	0.77 (4.54%)
Ex-Dividend Date	Dec 3, 2025

Volume	3,954,600
Average Volume	3,087,435
Open	16.93
Previous Close	16.84
Day's Range	16.67 - 16.96
52-Week Range	10.65 - 17.31
Beta	0.36
RSI	61.93
Earnings Date	Mar 5, 2026

About Fleury

Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In add...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1926
• Employees: 28,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: FLRY3

Financial Performance

In 2024, Fleury's revenue was 7.68 billion, an increase of 18.76% compared to the previous year's 6.47 billion. Earnings were 616.17 million, an increase of 45.41%.